User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Renal sympathetic denervation in the aftermath of Symplicity HTN-3

Primary tabs

Kjeldsen, Sverre E. Fadl Elmula, Fadl E. M. Persu, Alexandre [UCL] Jin, Yu Staessen, Jan A.
Document type Article de périodique (Journal article)
Access type Accès restreint
Publication date 2014
Language Anglais
Journal information "Blood Pressure" - Vol. 23, no.5, p. 256-261 (2014)
Peer reviewed yes
Publisher Informa Healthcare (London)
issn 0803-7051
e-issn 1651-1999
Publication status Publié
Affiliations UCL - SSS/IREC/CARD-Pôle de recherche cardiovasculaire
UCL - (SLuc) Service de cardiologie
Links
  1. Krum Henry, Schlaich Markus, Whitbourn Rob, Sobotka Paul A, Sadowski Jerzy, Bartus Krzysztof, Kapelak Boguslaw, Walton Anthony, Sievert Horst, Thambar Suku, Abraham William T, Esler Murray, Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study, 10.1016/s0140-6736(09)60566-3
  2. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial, 10.1016/s0140-6736(10)62039-9
  3. Krum Henry, Schlaich Markus P, Sobotka Paul A, Böhm Michael, Mahfoud Felix, Rocha-Singh Krishna, Katholi Richard, Esler Murray D, Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study, 10.1016/s0140-6736(13)62192-3
  4. Bhatt Deepak L., Kandzari David E., O'Neill William W., D'Agostino Ralph, Flack John M., Katzen Barry T., Leon Martin B., Liu Minglei, Mauri Laura, Negoita Manuela, Cohen Sidney A., Oparil Suzanne, Rocha-Singh Krishna, Townsend Raymond R., Bakris George L., A Controlled Trial of Renal Denervation for Resistant Hypertension, 10.1056/nejmoa1402670
  5. DeMaria Anthony N., Reflections on Renal Denervation, 10.1016/j.jacc.2014.03.001
  6. Von Euler U. S., Hellner S., Purkhold A., Excretion of Noradrenaline in Urine in Hypertension, 10.3109/00365515409134833
  7. Julius Stevo, Esler Murray, Autonomic nervous cardiovascular regulation in borderline hypertension, 10.1016/0002-9149(75)90170-8
  8. Esler M, Mayo Clin Proc, 52, 379 (1977)
  9. Eide I., Kolloch R., De Quattro V., Miano L., Dugger R., Van der Meulen J., Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension, 10.1161/01.hyp.1.3.255
  10. Esler M., Jackman G., Leonard P., Bobik A., Skews Helen, Jennings G., Kelleher Dianne, Korner P., Determination of Noradrenaline Uptake, Spillover to Plasma and Plasma Concentration in Patients with Essential Hypertension, 10.1042/cs059311s
  11. Kjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P., Increased Peripheral Release of Noradrenaline and Uptake of Adrenaline in Essential Hypertension?, 10.1042/cs061215s
  12. Kjeldsen Sverre E., Zweifler Andrew J., Petrin Jurij, Weder Alan B., Julius Stevo, Sympathetic Nervous System Involvement in Essential Hypertension: Increased Platelet Noradrenaline Coincides with Decreased β-Adrenoreceptor Responsiveness, 10.3109/08037059409102247
  13. Gifford RW, Hypertension, 11, I-171 (1988)
  14. Klein L. E., Compliance and blood pressure control., 10.1161/01.hyp.11.3_pt_2.ii61
  15. Ceral Jiri, Habrdova Vilma, Vorisek Viktor, Bima Marcel, Pelouch Radek, Solar Miroslav, Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy, 10.1038/hr.2010.183
  16. Staessen Jan A, Fagard Robert, Thijs Lutgarde, Celis Hilde, Arabidze Guramy G, Birkenhäger Willem H, Bulpitt Christopher J, de Leeuw Peter W, Dollery Colin T, Fletcher Astrid E, Forette Françoise, Leonetti Gastone, Nachev Choudomir, O' Brien Eoin T, Rosenfeld Joseph, Rodicio José L, Tuomilehto Jaakko, Zanchetti Alberto, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, 10.1016/s0140-6736(97)05381-6
  17. Dahlöf Björn, Devereux Richard B, Kjeldsen Sverre E, Julius Stevo, Beevers Gareth, de Faire Ulf, Fyhrquist Frej, Ibsen Hans, Kristiansson Krister, Lederballe-Pedersen Ole, Lindholm Lars H, Nieminen Markku S, Omvik Per, Oparil Suzanne, Wedel Hans, Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, 10.1016/s0140-6736(02)08089-3
  18. Julius Stevo, Kjeldsen Sverre E, Weber Michael, Brunner Hans R, Ekman Steffan, Hansson Lennart, Hua Tsushung, Laragh John, McInnes Gordon T, Mitchell Lada, Plat Francis, Schork Anthony, Smith Beverly, Zanchetti Alberto, Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial, 10.1016/s0140-6736(04)16451-9
  19. Howard James P, Nowbar Alexandra N, Francis Darrel P, Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4121 patients with focus on trial design: the CONVERGE report, 10.1136/heartjnl-2013-304238
  20. Shun-Shin M. J., Howard J. P., Francis D. P., Removing the hype from hypertension, 10.1136/bmj.g1937
  21. O’Brien Eoin, Blood Pressure Expert - An Application for i-phone that may help controlling hypertension better in the community : , 10.1097/01.hjh.0000432505.47413.d3
  22. Persu A, Hypertens Res (2014)
  23. Kikuya Masahiro, Hansen Tine W., Thijs Lutgarde, Björklund-Bodegård Kristina, Kuznetsova Tatiana, Ohkubo Takayoshi, Richart Tom, Torp–Pedersen Christian, Lind Lars, Ibsen Hans, Imai Yutaka, Staessen Jan A., Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk : , 10.1097/mbp.0b013e3282f2b53d
  24. Salles Gil F., Cardoso Claudia R. L., Muxfeldt Elizabeth S., Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension, 10.1001/archinte.168.21.2340
  25. Azizi M., Steichen O., Frank M., Bobrie G., Plouin P.-F., Sapoval M., Catheter-based Radiofrequency Renal-nerve Ablation in Patients with Resistant Hypertension, 10.1016/j.ejvs.2011.11.022
  26. Persu A., Renkin J., Thijs L., Staessen J. A., Renal Denervation: Ultima Ratio or Standard in Treatment-Resistant Hypertension, 10.1161/hypertensionaha.112.195263
  27. Staessen J. A., Thijs L., Bieniaszewski L., O'Brien E. T., Palatini P., Davidson C., Dobovisek J., Jaaskivi M., Laks T., Lehtonen A., Vanhanen H., Webster J., Ambulatory Monitoring Uncorrected for Placebo Overestimates Long-term Antihypertensive Action, 10.1161/01.hyp.27.3.414
  28. Luscher T. F., Mahfoud F., Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?, 10.1093/eurheartj/ehu195
  29. Persu A., Azizi M., Burnier M., Staessen J. A., Residual Effect of Renal Denervation in Patients With Truly Resistant Hypertension, 10.1161/hypertensionaha.113.01632
  30. Fadl Elmula F. E. M., Hoffmann P., Fossum E., Brekke M., Gjonnaess E., Hjornholm U., Kjaer V. N., Rostrup M., Kjeldsen S. E., Os I., Stenehjem A.-E., Hoieggen A., Renal Sympathetic Denervation in Patients With Treatment-Resistant Hypertension After Witnessed Intake of Medication Before Qualifying Ambulatory Blood Pressure, 10.1161/hypertensionaha.113.01452
  31. Persu Alexandre, Renkin Jean, Asayama Kei, O’Brien Eoin, Staessen Jan A, Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence, 10.1586/erc.13.52
  32. Persu A, Jin Y, Azizi M, Baelen M, Völz S, Elvan A, Severino F, Rosa J, Adiyaman A, Fadl Elmula F E, Taylor A, Pechère-Bertschi A, Wuerzner G, Jokhaji F, Kahan T, Renkin J, Monge M, Widimský P, Jacobs L, Burnier M, Mark P B, Kjeldsen S E, Andersson B, Sapoval M, Staessen J A, Blood pressure changes after renal denervation at 10 European expert centers, 10.1038/jhh.2013.88
  33. Helgeland A, The Oslo study. Am J Medicine, 69, 725 (1980)
  34. Brinkmann J., Heusser K., Schmidt B. M., Menne J., Klein G., Bauersachs J., Haller H., Sweep F. C., Diedrich A., Jordan J., Tank J., Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients: Prospective Case Series, 10.1161/hypertensionaha.112.201186
  35. Fadl Elmula FEM, Hypertension, 63, 691 (2014)
  36. Mahfoud F., Ukena C., Schmieder R. E., Cremers B., Rump L. C., Vonend O., Weil J., Schmidt M., Hoppe U. C., Zeller T., Bauer A., Ott C., Blessing E., Sobotka P. A., Krum H., Schlaich M., Esler M., Bohm M., Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension, 10.1161/circulationaha.112.000949
  37. Ott Christian, Mahfoud Felix, Schmid Axel, Ditting Tilmann, Sobotka Paul A., Veelken Roland, Spies Aline, Ukena Christian, Laufs Ulrich, Uder Michael, Böhm Michael, Schmieder Roland E., Renal Denervation in Moderate Treatment-Resistant Hypertension, 10.1016/j.jacc.2013.06.023
  38. Jin Y., Persu A., Staessen J. A., Letter by Jin et al Regarding Article, "Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension", 10.1161/circulationaha.113.005121
  39. Schmieder Roland E., Redon Josep, Grassi Guido, Kjeldsen Sverre E., Mancia Giuseppe, Narkiewicz Krzysztof, Parati Gianfranco, Ruilope Luis, van de Borne Philippe, Tsioufis Costas, ESH Position Paper : Renal denervation – an interventional therapy of resistant hypertension, 10.1097/hjh.0b013e328352ce78
  40. Schmieder RE, Euro Intervention, 9, R58 (2013)
  41. Schmieder RE, Advance online publication (2014)
  42. Pathak A, Euro Intervention, 10, 21 (2014)
  43. Longland C. J., Gibb W. E., Sympathectomy in the treatment of benign and malignant hypertension: A review of 76 patients, 10.1002/bjs.18004116814
  44. Smithwick Reginald H., SPLANCHNICECTOMY FOR ESSENTIAL HYPERTENSION : RESULTS IN 1,266 CASES, 10.1001/jama.1953.03690160001001
  45. Persu A., Jin Y., Baelen M., Vink E., Verloop W. L., Schmidt B., Blicher M. K., Severino F., Wuerzner G., Taylor A., Pechere-Bertschi A., Jokhaji F., Fadl Elmula F. E. M., Rosa J., Czarnecka D., Ehret G., Kahan T., Renkin J., Widimsky J., Jacobs L., Spiering W., Burnier M., Mark P. B., Menne J., Olsen M. H., Blankestijn P. J., Kjeldsen S., Bots M. L., Staessen J. A., , Eligibility for Renal Denervation: Experience at 11 European Expert Centers, 10.1161/hypertensionaha.114.03194
  46. Persu Alexandre, Jin Yu, Fadl Elmula Fadl Elmula Mohamed, Jacobs Lotte, Renkin Jean, Kjeldsen Sverre, Renal Denervation after Symplicity HTN-3: An Update, 10.1007/s11906-014-0460-x
  47. Oz M, Time Magazine, 28 (2012)
  48. Blech J, Der Spiegel, 28, 102 (2013)
  49. Bramley TJ, J Manag Care Pharm, 12, 239 (2006)
Bibliographic reference Kjeldsen, Sverre E. ; Fadl Elmula, Fadl E. M. ; Persu, Alexandre ; Jin, Yu ; Staessen, Jan A.. Renal sympathetic denervation in the aftermath of Symplicity HTN-3. In: Blood Pressure, Vol. 23, no.5, p. 256-261 (2014)
Permanent URL http://hdl.handle.net/2078.1/156683